Market Overview:
The global fatty acids supplement market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing awareness about the benefits of fatty acids supplements, rising demand for functional food and beverages, and growing trend of preventive healthcare. In addition, the increasing prevalence of lifestyle diseases is also contributing to the growth of this market. On the basis of type, omega-3 fatty acids are expected to account for a major share in this market during the forecast period. This can be attributed to their numerous health benefits such as reducing inflammation and improving heart health.
Product Definition:
A fatty acid supplement is a dietary supplement that provides the body with fatty acids. These supplements are typically made of oils or capsules that contain omega-3 and omega-6 fatty acids. Fatty acids are important for the body because they help to support cognitive function, joint health, and heart health.
Omega-3:
Omega-3 fatty acids are polyunsaturated fatty acids, which the human body is unable to produce on its own. They must be consumed through diet or supplementation. Omega-3 fatty acids are essential for health as they help in reducing triglyceride levels, decreasing inflammation and heart rate and lowering blood pressure levels. The regular consumption of omega 3 has been known to decrease the risk of heart attack by 40%, death from all causes by 23% and stroke by 22%.
Omega-6:
Omega-6 is a type of fatty acid. There are many different types of omega-6 fatty acids, but only two main ones that are used in dietary supplements: Linoleic Acid (LA) and Alpha-linolenic Acid (ALA). The reason these two are considered important is because they can be converted into other important fats for the body to use.
Application Insights:
Dietary supplements emerged as the largest application segment and accounted for a revenue share of over 47.0% in 2017. The global demand for dietary supplements is growing significantly owing to rising health concerns among individuals regarding their weight loss goals, increasing fitness levels, and maintaining a healthy lifestyle. Fatty acids are widely used in manufacturing nutritional products including infant formula, sports drinks, snacks bars & cereals and functional foods owing to their ability to reduce cholesterol levels thereby promoting heart health among consumers.
The other applications segment includes pharmaceuticals and cosmetics where they are used as emollients or foaming agents or both respectively.
Regional Analysis:
North America was the largest market for fatty acids supplements accounting for a share of more than 30.0% in 2017 owing to high consumption of fish oil and flaxseed oil as dietary supplements. Moreover, increasing awareness about health benefits associated with omega-3 fatty acid is expected to drive the regional demand over the forecast period.
Asia Pacific is projected to be one of the fastest growing markets at a CAGR exceeding 6.5% from 2018 to 2030 due to rising population coupled with increasing per capita income in emerging economies including China and India will boost product demand over the forecast period.
Growth Factors:
- Increasing awareness about the benefits of fatty acids supplements among consumers.
- Rising demand for natural and organic products.
- Growing popularity of preventive healthcare measures.
- Proliferation of online retail channels providing easy access to fatty acids supplements at competitive prices.
Scope Of The Report
Report Attributes
Report Details
Report Title
Fatty Acids Supplement Market Research Report
By Type
Omega-3, Omega-6, Other
By Application
Dietary Supplements, Functional Food & Beverages, Pharmaceutical and Infant Formula, Other
By Companies
Croda International, DSM, Clover Corporation, Omega Protein Corporation, Natrol, BASF, Orkla Health, BIOCARE, Epax Norway
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Fatty Acids Supplement Market Report Segments:
The global Fatty Acids Supplement market is segmented on the basis of:
Types
Omega-3, Omega-6, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Dietary Supplements, Functional Food & Beverages, Pharmaceutical and Infant Formula, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Croda International
- DSM
- Clover Corporation
- Omega Protein Corporation
- Natrol
- BASF
- Orkla Health
- BIOCARE
- Epax Norway
Highlights of The Fatty Acids Supplement Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Omega-3
- Omega-6
- Other
- By Application:
- Dietary Supplements
- Functional Food & Beverages
- Pharmaceutical and Infant Formula
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fatty Acids Supplement Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A fatty acids supplement is a dietary supplement that contains omega-3 and omega-6 fatty acids. These nutrients are important for overall health and can help to reduce the risk of heart disease, stroke, and other chronic conditions.
Some of the major companies in the fatty acids supplement market are Croda International, DSM, Clover Corporation, Omega Protein Corporation, Natrol, BASF, Orkla Health, BIOCARE, Epax Norway.
The fatty acids supplement market is expected to register a CAGR of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Fatty Acids Supplement Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Fatty Acids Supplement Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Fatty Acids Supplement Market - Supply Chain
4.5. Global Fatty Acids Supplement Market Forecast
4.5.1. Fatty Acids Supplement Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Fatty Acids Supplement Market Size (000 Units) and Y-o-Y Growth
4.5.3. Fatty Acids Supplement Market Absolute $ Opportunity
5. Global Fatty Acids Supplement Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Fatty Acids Supplement Market Size and Volume Forecast by Type
5.3.1. Omega-3
5.3.2. Omega-6
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Fatty Acids Supplement Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Fatty Acids Supplement Market Size and Volume Forecast by Application
6.3.1. Dietary Supplements
6.3.2. Functional Food & Beverages
6.3.3. Pharmaceutical and Infant Formula
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Fatty Acids Supplement Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Fatty Acids Supplement Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Fatty Acids Supplement Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Fatty Acids Supplement Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Fatty Acids Supplement Demand Share Forecast, 2019-2026
9. North America Fatty Acids Supplement Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Fatty Acids Supplement Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Fatty Acids Supplement Market Size and Volume Forecast by Application
9.4.1. Dietary Supplements
9.4.2. Functional Food & Beverages
9.4.3. Pharmaceutical and Infant Formula
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Fatty Acids Supplement Market Size and Volume Forecast by Type
9.7.1. Omega-3
9.7.2. Omega-6
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Fatty Acids Supplement Demand Share Forecast, 2019-2026
10. Latin America Fatty Acids Supplement Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Fatty Acids Supplement Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Fatty Acids Supplement Market Size and Volume Forecast by Application
10.4.1. Dietary Supplements
10.4.2. Functional Food & Beverages
10.4.3. Pharmaceutical and Infant Formula
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Fatty Acids Supplement Market Size and Volume Forecast by Type
10.7.1. Omega-3
10.7.2. Omega-6
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Fatty Acids Supplement Demand Share Forecast, 2019-2026
11. Europe Fatty Acids Supplement Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Fatty Acids Supplement Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Fatty Acids Supplement Market Size and Volume Forecast by Application
11.4.1. Dietary Supplements
11.4.2. Functional Food & Beverages
11.4.3. Pharmaceutical and Infant Formula
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Fatty Acids Supplement Market Size and Volume Forecast by Type
11.7.1. Omega-3
11.7.2. Omega-6
11.7.3. Other
11.8. Basis Pint Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Fatty Acids Supplement Demand Share, 2019-2026
12. Asia Pacific Fatty Acids Supplement Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Fatty Acids Supplement Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Fatty Acids Supplement Market Size and Volume Forecast by Application
12.4.1. Dietary Supplements
12.4.2. Functional Food & Beverages
12.4.3. Pharmaceutical and Infant Formula
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Fatty Acids Supplement Market Size and Volume Forecast by Type
12.7.1. Omega-3
12.7.2. Omega-6
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Fatty Acids Supplement Demand Share, 2019-2026
13. Middle East & Africa Fatty Acids Supplement Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Fatty Acids Supplement Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Fatty Acids Supplement Market Size and Volume Forecast by Application
13.4.1. Dietary Supplements
13.4.2. Functional Food & Beverages
13.4.3. Pharmaceutical and Infant Formula
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Fatty Acids Supplement Market Size and Volume Forecast by Type
13.7.1. Omega-3
13.7.2. Omega-6
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Fatty Acids Supplement Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Fatty Acids Supplement Market: Market Share Analysis
14.2. Fatty Acids Supplement Distributors and Customers
14.3. Fatty Acids Supplement Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Croda International
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. DSM
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Clover Corporation
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Omega Protein Corporation
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Natrol
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. BASF
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Orkla Health
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. BIOCARE
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Epax Norway
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
